Evidence map›Paper›PMID 31801353›Full record

ArticleJournal of diabetes science and technology2020

Suicide and Self-inflicted Injury in Diabetes: A Balancing Act.

Katharine D Barnard-Kelly, Diana Naranjo, Shideh Majidi, Halis K Akturk, Marc Breton, Philippe Courtet, Emilie Olié, Rayhan A Lal, Nicole Johnson, Eric Renard

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Katharine D Barnard-KellyFaculty of Health and Social Science, Bournemouth University, UK.ORCID 0000-0002-3888-3123
Diana NaranjoStanford Diabetes Research Center, CA, USA.ORCID 0000-0001-8039-0616
Shideh MajidiBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA.
Halis K AkturkBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA.ORCID 0000-0003-4518-5179
Marc BretonCenter for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.
Philippe CourtetPsychiatric Emergency and Acute Care, Lapeyronie Hospital, University of Montpellier, France.
Emilie OliéPsychiatric Emergency and Acute Care, Lapeyronie Hospital, University of Montpellier, France.
Rayhan A LalStanford Diabetes Research Center, CA, USA.
Nicole JohnsonJDRF, New York, NY, USA.
Eric RenardDepartment of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, France.ORCID 0000-0002-3407-7263
Université de Montpellier · FRUniversity of Colorado Anschutz Medical Campus · USBournemouth University · GBChapter Arts Centre · GBUniversity of Virginia · US

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Training Research Leaders in Type 1 DiabetesK12DK122550 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2019 to 2023
$2.1M
NIDDK NIH HHS K12 DK122550NIDDK NIH HHS P30 DK116074
6 · The paper itself

Abstract

Glycemic control in type 1 diabetes mellitus (T1DM) remains a challenge for many, despite the availability of modern diabetes technology. While technologies have proven glycemic benefits and may reduce excess mortality in some populations, both mortality and complication rates remain significantly higher in T1DM than the general population. Diabetes technology can reduce some burdens of diabetes self-management, however, it may also increase anxiety, stress, and diabetes-related distress. Additional workload associated with diabetes technologies and the dominant focus on metabolic control may be at the expense of quality-of-life. Diabetes is associated with significantly increased risk of suicidal ideation, self-harm, and suicide. The risk increases for those with diabetes and comorbid mood disorder. For example, the prevalence of depression is significantly higher in people with diabetes than the general population, and thus, people with diabetes are at even higher risk of suicide. The Center for Disease Control and Prevention reported a 24% rise in US national suicide rates between 1999 and 2014, the highest in 30 years. In the United Kingdom, 6000 suicides occur annually. Rates of preventable self-injury mortality stand at 29.1 per 100 000 population. Individuals with diabetes have an increased risk of suicide, being three to four times more likely to attempt suicide than the general population. Furthermore, adolescents aged 15 to 19 are most likely to present at emergency departments for self-inflicted injuries (9.6 per 1000 visits), with accidents, alcohol-related injuries, and self-harm being the strongest risk factors for suicide, the second leading cause of death among 10 to 24 year olds. While we have developed tools to improve glycemic control, we must be cognizant that the psychological burden of chronic disease is a significant problem for this vulnerable population. It is crucial to determine the psychosocial and behavioral predictors to uptake and continued use of technology in order to aid the identification of those individuals most likely to realize benefits of any intervention as well as those individuals who may require more support to succeed with technology.

Indexed as

Cost of IllnessAdaptation, PsychologicalAdolescentAdultAge FactorsDiabetes Mellitus, Type 1FemaleHealth BehaviorHealth Knowledge, Attitudes, PracticeHumansMaleRisk AssessmentRisk FactorsSelf CareSelf-Injurious BehaviorSuicidediabetesself-harmself-inflicted injurysuicide

Identifiers

PMID31801353
PMCPMC7645123
OpenAlexW2993191622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.